LG Chem (A051910) Stock Overview
Operates as a chemical company in Korea, China, Asia/Oceania, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
A051910 Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
₩344.88k
FV
24.9% undervalued intrinsic discount86
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
LG Chem, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩259,000.00 |
| 52 Week High | ₩437,500.00 |
| 52 Week Low | ₩243,000.00 |
| Beta | 1.39 |
| 1 Month Change | -12.94% |
| 3 Month Change | -33.84% |
| 1 Year Change | -15.64% |
| 3 Year Change | -60.15% |
| 5 Year Change | -69.24% |
| Change since IPO | 1,939.37% |
Recent News & Updates
Narrative Update • Jul 22
A051910: New Oncology Collaborations And Semiconductor Materials Will Support Future Upside
The analyst fair value estimate for LG Chem has changed from ₩322,573.53 to ₩301,085.24. Analysts cite updated assumptions for revenue growth, profit margins, the discount rate, and future P/E expectations as the key factors behind this revision.Narrative Update • Jul 08
A051910: New Oncology Partnerships Will Support Future Upside Despite Governance Concerns
Analysts have updated their valuation on LG Chem, trimming the fair value estimate from ₩330,040 to ₩322,574 as they adjust assumptions for discount rate, revenue growth, profit margin, and future P/E. What's in the News OTR Therapeutics entered a collaboration agreement with LG Chem to identify, evaluate, and develop oncology assets from China, combining OTR's R&D platform and regional network with LG Chem's global development expertise and commercial infrastructure.Narrative Update • Jun 16
A051910: Governance Disputes Will Likely Cap Stock Upside Despite Earnings Assumptions
Analysts now set LG Chem's fair value at approximately ₩330,040, up from about ₩328,010. This reflects revised assumptions for revenue growth, profit margin and a slightly lower future P/E multiple.
Narrative Update • Jun 02
A051910: Governance Reforms Will Support Future Upside Despite Lower Assumed P E
Analysts have nudged their price target for LG Chem higher from ₩421,500 to about ₩441,640. This reflects updated assumptions around revenue growth, profit margins, a lower anticipated future P/E multiple, and a slightly reduced discount rate.
Narrative Update • May 16
A051910: Licensing Agreement And Governance Reforms Will Support Future Earnings Power
Analysts reaffirmed LG Chem's fair value estimate at ₩540,000 per share, citing updated assumptions that reflect a lower discount rate, slightly higher revenue growth expectations, improved profit margin forecasts, and a reduced future P/E multiple. What's in the News Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside Greater China.Recent updates
Narrative Update • Jul 22
A051910: New Oncology Collaborations And Semiconductor Materials Will Support Future Upside
The analyst fair value estimate for LG Chem has changed from ₩322,573.53 to ₩301,085.24. Analysts cite updated assumptions for revenue growth, profit margins, the discount rate, and future P/E expectations as the key factors behind this revision.Narrative Update • Jul 08
A051910: New Oncology Partnerships Will Support Future Upside Despite Governance Concerns
Analysts have updated their valuation on LG Chem, trimming the fair value estimate from ₩330,040 to ₩322,574 as they adjust assumptions for discount rate, revenue growth, profit margin, and future P/E. What's in the News OTR Therapeutics entered a collaboration agreement with LG Chem to identify, evaluate, and develop oncology assets from China, combining OTR's R&D platform and regional network with LG Chem's global development expertise and commercial infrastructure.Narrative Update • Jun 16
A051910: Governance Disputes Will Likely Cap Stock Upside Despite Earnings Assumptions
Analysts now set LG Chem's fair value at approximately ₩330,040, up from about ₩328,010. This reflects revised assumptions for revenue growth, profit margin and a slightly lower future P/E multiple.Narrative Update • Jun 02
A051910: Governance Reforms Will Support Future Upside Despite Lower Assumed P E
Analysts have nudged their price target for LG Chem higher from ₩421,500 to about ₩441,640. This reflects updated assumptions around revenue growth, profit margins, a lower anticipated future P/E multiple, and a slightly reduced discount rate.Narrative Update • May 16
A051910: Licensing Agreement And Governance Reforms Will Support Future Earnings Power
Analysts reaffirmed LG Chem's fair value estimate at ₩540,000 per share, citing updated assumptions that reflect a lower discount rate, slightly higher revenue growth expectations, improved profit margin forecasts, and a reduced future P/E multiple. What's in the News Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside Greater China.Narrative Update • May 02
A051910: Governance Tensions And Modest Margin Outlook Will Likely Restrain Future Upside
Analysts have raised LG Chem's fair value estimate from ₩313,081.20 to ₩328,010.40, reflecting a slightly lower discount rate, a modestly higher profit margin outlook, and an updated future P/E assumption. What's in the News Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside Greater China.Narrative Update • Apr 17
A051910: Governance Reforms And Higher Future P E Will Support Upside
Analysts have nudged their fair value estimate for LG Chem down from ₩433,115 to ₩421,500, reflecting a slightly lower revenue growth outlook and profit margin assumptions, along with a modestly adjusted discount rate and future P/E. What's in the News Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside of Greater China.Narrative Update • Apr 01
A051910: Governance Reforms And Licensing Deal Will Support Long Term Earnings Power
Analysts kept their fair value estimate for LG Chem steady at ₩540,000 by adjusting assumptions around discount rate, revenue growth, profit margin and future P/E, and used these updates to reaffirm their price target without changing the headline figure. What's in the News Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside Greater China.Narrative Update • Mar 18
A051910: Dividend Outlook And Revised Assumptions Will Likely Keep Shares Fairly Priced
Analysts now place LG Chem's fair value at about ₩313,081 per share, compared with the prior ₩310,000. This reflects updated views on slower revenue growth, thinner profit margins, a slightly lower discount rate, and a higher assumed future P/E multiple.Narrative Update • Mar 04
A051910: Lower Discount Rate And Higher Future P/E Will Support Upside
Analysts have nudged their fair value estimate for LG Chem from ₩424,769 to ₩433,115, reflecting a slightly lower discount rate and an updated future P/E assumption, while keeping long term revenue growth and profit margin expectations broadly consistent. What's in the News LG Chem announced an annual dividend of ₩2,000.0000 per share, with an ex dividend date of March 30, 2026 and a record date of March 31, 2026 (Key Developments).Narrative Update • Feb 18
A051910: Higher Future P/E Assumptions Will Support Long-Term Upside
Analysts have raised their price target on LG Chem to ₩424,769 from ₩420,222, citing updated assumptions for revenue growth, profit margins and future P/E multiples. What's in the News LG Chem announced an annual dividend of ₩2,000.0000 per share, with an ex dividend date of March 30, 2026, and a record date of March 31, 2026 (Key Developments).Narrative Update • Feb 04
A051910: Higher Future P/E Assumptions Will Support Long-Term Upside
Analysts now see LG Chem's fair value at ₩420,222, down from ₩432,333, citing updated assumptions around a higher discount rate, a lower revenue growth outlook, slimmer profit margins and a higher future P/E multiple. What's in the News LG Chem announced an annual dividend of ₩2,000.0000 per share, with an ex-date set for March 30, 2026, and a record date of March 31, 2026 (Key Developments).Analysis Article • Jan 29
Sentiment Still Eluding LG Chem, Ltd. (KRX:051910)
It's not a stretch to say that LG Chem, Ltd.'s ( KRX:051910 ) price-to-sales (or "P/S") ratio of 0.6x right now seems...Narrative Update • Jan 21
A051910: Long-Term Holography Alliance Will Likely Keep Shares Fairly Priced
Analysts have raised their fair value estimate for LG Chem from ₩259,676 to ₩310,000, reflecting updated assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News ZEISS and LG Chem agreed on a long-term alliance for photopolymer film supply at industrial scale to support ZEISS Holographic Windshield Displays in automotive applications (Key Developments).Analysis Article • Jan 10
Is LG Chem (KRX:051910) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Jan 07
A051910: Long-Term Holography Alliance Will Likely Leave Shares Priced Too Optimistically
Analysts have lifted their price target for LG Chem from ₩250,535 to ₩259,676. They cite updates to their models that factor in revised assumptions for revenue growth, profit margins, discount rate and future P/E.Narrative Update • Dec 23
A051910 Translucent Display Materials Alliance Will Drive Long Term Earnings Power
Analysts have raised their fair value estimate for LG Chem from 436,206 KRW to 540,000 KRW, citing expectations for stronger revenue growth, a lower discount rate, and a higher justified future P/E multiple, despite slightly softer profit margin assumptions. What's in the News ZEISS and LG Chem formed a strategic alliance to supply robust, sustainable photopolymer films at industrial scale, supporting the emerging holography industry and advanced optical applications in mobility and consumer tech (Key Developments).Analysis Article • Dec 20
Here's What's Concerning About LG Chem's (KRX:051910) Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Narrative Update • Dec 09
A051910: Alliance For Future Windshield Displays Will Support Long-Term Upside
Analysts have modestly lowered their price target on LG Chem to approximately 432,300 KRW from about 437,400 KRW. This reflects slightly softer long term revenue growth assumptions and a marginally lower future earnings multiple, partly offset by a small improvement in projected profit margins and risk profile.Narrative Update • Nov 25
A051910: Industry Partnership Will Drive Adoption Of Automotive Display Technology
Analysts have raised their price target for LG Chem from ₩421,307.69 to ₩437,423.08. They cited improved forecasts for revenue growth and profit margins as key drivers behind the upward revision.Narrative Update • Nov 08
A051910: Improved Profitability And Industry Partnerships Will Support Future Performance
Narrative Update on LG Chem: Analyst Price Target Revision Analysts have raised their fair value estimate for LG Chem from 354,076.92 KRW to 421,307.69 KRW. This change is attributed to improved revenue growth projections and a stronger profit margin outlook.Narrative Update • Oct 25
Decarbonization And US Supply Chains Will Generate Future Momentum
Analysts have raised their price target for LG Chem from ₩344,481 to ₩354,077, citing a slightly lower discount rate as well as a stable outlook for revenue growth and profit margins. Valuation Changes Fair Value Estimate: increased marginally from ₩344,481 to ₩354,077 Discount Rate: decreased from 10.51% to 9.56% Revenue Growth Forecast: declined slightly from 11.07% to 10.89% Net Profit Margin Projection: lowered from 4.67% to 4.61% Future P/E Ratio: edged up from 11.63x to 11.88xAnalysis Article • Oct 16
LG Chem, Ltd. (KRX:051910) Doing What It Can To Lift Shares
There wouldn't be many who think LG Chem, Ltd.'s ( KRX:051910 ) price-to-sales (or "P/S") ratio of 0.5x is worth a...Analysis Article • Sep 25
Is LG Chem (KRX:051910) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Sep 04
The Returns On Capital At LG Chem (KRX:051910) Don't Inspire Confidence
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Narrative Update • Aug 11
Advancements In Chemical Recycling And Bio-Materials Will Strengthen Competitive Edge
The upward revision in LG Chem’s Analyst Price Target appears primarily driven by a notable increase in the forecasted Future P/E multiple, despite a slight decline in expected revenue growth, resulting in a new price target of ₩344,222. Valuation Changes Summary of Valuation Changes for LG Chem The Consensus Analyst Price Target has risen from ₩327370 to ₩344222.New Narrative • Mar 20
LG Chem's future valuation is set to take off as fair value approaches 767351.04
Expect recovery in the petrochemical sector and improved margins.
New Narrative • Nov 08
Innovative Materials And Energy Solutions Drive Future Profitability Amidst Global Challenges
Improved profitability in Petrochemical division due to higher spreads, new plant utilization, and expanded shipments boosts future operating profit.Shareholder Returns
| A051910 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | -0.6% | 0.6% | -2.3% |
| 1Y | -15.6% | -5.6% | 97.1% |
Return vs Industry: A051910 underperformed the KR Chemicals industry which returned -2.6% over the past year.
Return vs Market: A051910 underperformed the KR Market which returned 109.4% over the past year.
Price Volatility
| A051910 volatility | |
|---|---|
| A051910 Average Weekly Movement | 10.0% |
| Chemicals Industry Average Movement | 9.0% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in KR Market | 17.1% |
| 10% least volatile stocks in KR Market | 5.0% |
Stable Share Price: A051910 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A051910's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | n/a | Dong-Choon Kim | www.lgchem.com |
LG Chem, Ltd., together with its subsidiaries, operates as a chemical company in Korea, China, Asia/Oceania, the United States, Europe, and internationally. It offers ethylene-based synthetic resin products, such as ethylene vinyl acetate, high density polyethylene, low density polyethylene, linear low-density polyethylene, polyolefin elastomer, polyvinyl chloride, metallocene PE, and UNIQABLE, a recyclable all-PE packaging solution; and styrene-based synthetic resin, including acrylonitrile butadiene styrene, acrylonitrile styrene acrylate, expandable polystyrene, polystyrene, styrene acrylonitrile copolymer. The company also provides polycarbonate, a benzene-based synthetic resin product; polypropylene, a propylene-based synthetic resin; superabsorbent polymer; butadiene rubber, nitrile butadiene rubber, nitrile butadiene rubber latex, styrene butadiene latex, and solution styrene butadiene rubber; caustic soda; plasticizer; and base oil.
LG Chem, Ltd. Fundamentals Summary
| A051910 fundamental statistics | |
|---|---|
| Market cap | ₩19.21t |
| Earnings (TTM) | -₩2.68t |
| Revenue (TTM) | ₩45.60t |
0.4x
P/S Ratio-7.6x
P/E RatioIs A051910 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A051910 income statement (TTM) | |
|---|---|
| Revenue | ₩45.60t |
| Cost of Revenue | ₩37.95t |
| Gross Profit | ₩7.65t |
| Other Expenses | ₩10.33t |
| Earnings | -₩2.68t |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 31, 2026
| Earnings per share (EPS) | -34.27k |
| Gross Margin | 16.77% |
| Net Profit Margin | -5.88% |
| Debt/Equity Ratio | 72.0% |
How did A051910 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield-6%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/24 17:58 |
| End of Day Share Price | 2026/07/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LG Chem, Ltd. is covered by 42 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyunghee Chung | Barclays |
| NEIL BEVERIDGE | Bernstein |
| Joon-Ho Lee | BofA Global Research |